Array of cutaneous adverse effects associated with sorafenib

Journal of the American Academy of Dermatology

Volumn 61, Issue 2, 2009, Pages 360-361

  Kong, Heidi H ^a   Turner, Maria L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SORAFENIB;

ALOPECIA; CANCER PATIENT; DRUG DOSE REDUCTION; DYSESTHESIA; ERUPTIVE NEVUS; FACE ERYTHEMA; HAND FOOT SYNDROME; HUMAN; KERATOACANTHOMA; KERATOSIS PILARIS LIKE ERUPTION; LETTER; LEUKOCYTOCLASTIC VASCULITIS; NAIL DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RASH; SEBORRHEIC KERATOSIS; SKIN BIOPSY; SOLID TUMOR; STOMATITIS;

BENZENESULFONATES; BIOPSY, NEEDLE; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG ERUPTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; PYRIDINES; RISK ASSESSMENT; SKIN DISEASES;

EID: 67650113975     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.02.004     Document Type: Letter

References (5)

1. Robert C., Mateus C., Spatz A., Wechsler J., and Escudier B. Dermatologic symptoms associated with the multikinase inhibitor sorafenib. J Am Acad Dermatol 60 (2009) 299-305
2. Kong H.H., Sibaud V., Chanco Turner M.L., Fojo T., Hornyak T.J., and Chevreau C. Sorafenib-induced eruptive melanocytic lesions. Arch Dermatol 144 (2008) 820-822
3. Azad N.S., Aragon-Ching J.B., Dahut W.L., Gutierrez M., Figg W.D., Jain L., et al. Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-VEGF therapy. Clin Cancer Res 15 (2009) 1411-1416
4. Chung N.M., Gutierrez M., and Turner M.L. Leukocytoclastic vasculitis masquerading as hand-foot syndrome in a patient treated with sorafenib. Arch Dermatol 142 (2006) 1510-1511
5. Autier J., Escudier B., Wechsler J., Spatz A., and Robert C. Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor. Arch Dermatol 144 (2008) 886-892